CytoSite Bio (CytoSite) announced today that they have signed a collaboration agreement for the clinical development and potential commercialization of CytoSite's investigational Phase 1 ready ...
A 21-year-old man, who had been suffering from epilepsy for 10 years, was finally cured of the neurological disease after an ...
• In advanced-stage HL, reduction of chemotherapy or radiotherapy after a negative interim PET scan is probably beneficial for overall survival. • Treatment escalation with rituximab after a positive ...
A study in Alzheimer’s & Dementia, a leading journal in dementia research, has demonstrated the high accuracy of plasma ...
C2N’s test is designed for individuals aged 55 and above who exhibit signs or symptoms of mild cognitive impairment or ...
According to Telix Pharmaceuticals, the product has a longer shelf-life (up to 6 hours) and an extended distribution radius compared with other gallium-based products.
Telix Pharmaceuticals reported that the U.S. Food and Drug Administration approved its agent indicated for prostate cancer ...
For individuals with dominantly inherited Alzheimer disease (DIAD), long-term treatment with gantenerumab, an anti-amyloid ...
A rare case has been reported of diffuse large B-cell lymphoma (DLBCL) presenting initially as cold agglutinin disease (CAD). The report, published in the Kaohsiung Journal of Medical Sciences, ...